[Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].

Author: NesterovV V, ShkolnikE L, ShkolnikL D, VarlanG V, VasyukY A

Paper Details 
Original Abstract of the Article :
Anthracyclines including doxorubicin, epirubicin, daunorubicin, aclarubicin are extensively used as chemotherapeutic agents for treatment of hematological and other malignancies. In cancer therapy anthracyclines are often used in combinations with other chemotherapeutic drugs and agents for molecula...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/28290807

データ提供:米国国立医学図書館(NLM)

Anthracycline Cardiotoxicity: A Camel's Guide to Prevention

Anthracyclines are powerful weapons in the fight against cancer, like a camel's endurance in the desert. However, their use comes with a significant side effect: cardiotoxicity. This study delves into the current understanding of anthracycline-induced heart damage, emphasizing the importance of prevention and early detection.

The study focuses on the clinical implications of anthracycline cardiotoxicity, emphasizing the need for early intervention. It highlights the progressive and irreversible nature of this side effect, making prevention and early detection critical. The researchers emphasize the importance of incorporating cardiology expertise into cancer treatment plans to minimize the risk of cardiotoxicity. This research serves as a beacon in the desert of cancer treatment, illuminating the path towards safer and more effective therapies.

Navigating the Terrain: Early Detection and Prevention

This research underscores the importance of proactive strategies in cancer treatment. By focusing on early detection and prevention, we can mitigate the risks associated with anthracycline cardiotoxicity. This study serves as a reminder to healthcare professionals to prioritize cardiovascular monitoring in patients receiving anthracyclines, ensuring prompt intervention if necessary.

A Camel's Advice: Safeguarding Heart Health

While anthracyclines are crucial weapons in the fight against cancer, it's essential to remember that their use comes with potential risks. This research underscores the importance of a multidisciplinary approach to cancer care, involving both oncologists and cardiologists to ensure the best possible outcomes for patients. By recognizing the potential for heart damage and taking proactive steps to prevent it, we can help patients navigate the desert of cancer treatment with greater confidence and well-being.

Dr. Camel's Conclusion

Navigating the desert of cancer treatment is a complex and challenging journey. This study serves as a valuable guide, emphasizing the importance of addressing potential side effects, such as anthracycline cardiotoxicity. The call for early detection and prevention highlights the need for a collaborative and vigilant approach to patient care, ensuring that patients receive the best possible treatment while minimizing potential risks.

Date :
  1. Date Completed 2018-07-13
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28290807

DOI: Digital Object Identifier

28290807

Related Literature

SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.